Pay in 4 interest-free payments of $6.60 Learn more
Ships within 48 hours · Estimated delivery Sep 5 - Sep 10
In 2005, the US Food and Drug Administration gave it the green light under the brand name Byetta, making it the very first GLP-1 receptor agonist approved for type 2 diabetes
Reassess and Refine: Listen to your body
In 2005, the FDA approved exenatide (Byetta) for the treatment of type 2 diabetes mellitus
Furthermore, there has been an indication of tirzepatide reducing liver fat, and improving nephrotic outcomes as evidenced by the lower urine albumin: creatinine ratio and the slower decline of estimated glomerular filtration rate in people with T2DM [56]
US$ 20.69
US$ 29.88
US$ 23.03
US$ 24.90
